New this year, DEF has introduced a theme for the series, inspired by the popular Harry Potter books and movies. “Master the ...

The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...

From a valuation standpoint, Amgen is reasonably priced. Going by the price/earnings ratio, the company’s shares currently trade at 13.12 forward earnings, which is lower than 14.74 for the industry.

New biologic and targeted therapies are changing the landscape of prurigo nodularis care, offering sustained relief and ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in ...

Medically reviewed by Katlein Franca, MD Atopic dermatitis may be more challenging for healthcare providers to identify ...

Using the TriNetX federated health care database, researchers conducted a propensity score-matched retrospective cohort study of pregnant patients aged 12 to 55 years with T2IDs (eg, atopic dermatitis ...

Sanofi SNY reported first-quarter 2025 adjusted earnings of 94 cents per American depositary share, which beat the Zacks Consensus Estimate of 90 cents per share. Earnings of €1.79 per share rose 17.0 ...

eosinophilic esophagitis and prurigo nodularis. However, customary dynamics of the annual reset of insurance plans in the first quarter hurt sales slightly. Dupixent sales rose 23.5% in Europe and ...

The drug is approved for prurigo nodularis and atopic dermatitis. RBC described the launch as ahead of expectations and noted strong early uptake across both indications. Jefferies emphasized ...